Stevens-Johnson syndrome and toxic epidermal necrolysis: a 10-year experience in a burns unit.

Journal of Wound Care
Khosrow S HouschyarFrank Siemers

Abstract

Stevens-Johnson syndrome (SJS) and its more severe counterpart, toxic epidermal necrolysis (TEN), are skin hypersensitivity reactions defined by epidermal blistering and necrosis. The exact pathophysiology of SJS/TEN is yet to be deciphered, but a number of risk factors have been identified including adverse drug reactions. The diagnosis of SJS/TEN is made on a clinical basis, and treatment consists of supportive care and occasionally immunosuppressants, such as cyclosporin, high-dose intravenous immunoglobulins and/or corticosteroids. Mortality rates can reach 20-25% in adults but are reduced with early intervention. To identify optimal treatment regimens, to better understand the patient cohort affected, and to help identify key risk factors for mortality, we report our experience with the treatment and management of SJS/TEN patients. A retrospective review of consecutive patients with SJS and/or TEN admitted to a single burns centre in Germany, between 2008 and 2018, was conducted. The primary outcomes of demographics, clinical course, treatment and patient-reported outcomes were recorded and compared with a control group of patients with burns without a diagnosis of SJS/TEN. A total of 23 patients with SJS/TEN met the inclu...Continue Reading

References

Aug 22, 2000·The Journal of Investigative Dermatology·S Bastuji-GarinP Wolkenstein
Mar 8, 2002·The Journal of Burn Care & Rehabilitation·T L PalmieriF Molitor
Feb 21, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Mohammad S AlavijehAlan M Palmer
Dec 13, 2006·Journal of Pediatric Surgery·José AszRobert P Foglia
Jan 17, 2007·Journal of the American Academy of Dermatology·Frederick A PereiraDavid M Rosmarin
Dec 18, 2010·Orphanet Journal of Rare Diseases·Thomas Harr, Lars E French
Mar 2, 2011·Critical Care Medicine·Roland GerullThomas Schaible
Jan 31, 2013·Genome Medicine·Ann K Daly
Jul 23, 2013·Journal of the American Academy of Dermatology·Robert A SchwartzBrian W Lee
Mar 7, 2014·Medical Journal, Armed Forces India·Rajesh VermaVijendran Pragasam
Apr 14, 2015·Burns : Journal of the International Society for Burn Injuries·Hajirah SaeedJames Chodosh
Aug 9, 2015·The Journal of Allergy and Clinical Immunology·Katie D WhiteElizabeth J Phillips
Jan 27, 2016·Burns : Journal of the International Society for Burn Injuries·Hong-Gam LeJames Chodosh
Jun 22, 2017·The Journal of Investigative Dermatology·Carlos González-HerradaUNKNOWN PIELenRed Therapeutic Management Working Group
Jan 10, 2018·The Journal of Allergy and Clinical Immunology. in Practice·Katie D WhiteElizabeth J Phillips
Apr 9, 2018·Burns : Journal of the International Society for Burn Injuries·Anthony PappJan Dutz
Apr 11, 2018·Journal of Inflammation Research·Qin Xiang NgWee-Song Yeo
Jun 15, 2018·Journal of Burn Care & Research : Official Publication of the American Burn Association·Emily B RichardHollis R O'Neal
Mar 12, 2019·Plastic Surgery·Khosrow Siamak HouschyarFrank Siemers
Jan 7, 2020·BMC Health Services Research·H Khalil, C Huang
Jan 9, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·I Torres-NavarroR Botella-Estrada

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.